Methodological issues in studies of major depression and schizophrenia. Implications for the "Committee for proprietary medicinal products" guidelines

Authors	J.G. Storosum
Supervisors	A.W. Broekmans B.P.R. Gersons
Cosupervisors	A.J.A. Elferink B.J. van Zwieten
Award date	12-04-2002
Number of pages	110
Organisations	Faculty of Medicine (AMC-UvA)
Document type	PhD thesis
Note	Research conducted at: AmCOGG
Language	English
Downloads	Thesis Cover Titlepage Contents List of Abbreviations 1. General introduction and objectives of the studies 2. Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study 3. Suicide risk in placebo-controlled trials for major depression 4. Relapse and recurrence prevention in major depression: a review of placebo-controlled efficacy studies with special emphasis on methodological issues. 5. Schizophrenia: Do we really need placebo-controlled studies? 6. Amisulpride: Is there a treatment for negative symptoms in schizophrenic patients? 7. General discussion Summary Samenvatting Dankwoord 1 Dankwoord 2 Dankwoord STELLINGEN Cover
Permalink to this page

Back

UvA-DARE